Valuation: Amgen Inc.

Market Cap 228B 201B 190B 172B 324B 21,850B 328B 2,275B 875B 11,170B 856B 837B 35,812B P/E 2026 *
26.6x
P/E 2027 * 23.8x
Enterprise Value 269B 237B 225B 203B 382B 25,828B 387B 2,689B 1,035B 13,204B 1,011B 989B 42,331B EV / Sales 2026 *
6.92x
EV / Sales 2027 * 6.54x
Free-Float
99.77%
Yield 2026 *
2.39%
Yield 2027 * 2.53%
1 day-0.50%
1 week+3.80%
1 month-1.95%
3 months+16.40%
6 months+19.80%
Current year+28.78%
1 week 404.19
Extreme 404.19
426.59
1 month 374.46
Extreme 374.46
445.82
Current year 318.21
Extreme 318.21
447.03
1 year 288
Extreme 288
447.03
3 years 249.7
Extreme 249.7001
447.03
5 years 198.64
Extreme 198.64
447.03
10 years 133.64
Extreme 133.64
447.03
Manager TitleAgeSince
Chief Executive Officer 63 2012-04-30
Director of Finance/CFO 62 2010-05-12
Chief Tech/Sci/R&D Officer 57 2023-05-31
Director TitleAgeSince
Chairman 63 2012-12-31
Director/Board Member 65 2011-12-31
Director/Board Member 71 2011-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
9/1/26 Other

Chief Financial Officer

34,061 0.0063%
8/13/26 Exercice

Executive/Senior Manager

3,756 0.0007%
8/7/26 Free

Director

85 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.50%+3.80%+49.37%+56.84% 229B
-2.33%+0.53%+51.65%+115.42% 1,056B
-1.06%-1.65%+42.78%+69.98% 645B
-0.65%-1.32%+12.98%+75.49% 465B
-2.66%-1.87%+73.13%+41.15% 368B
-0.06%-3.88%+34.32%+39.39% 335B
-0.79%+2.01%+19.82%+27.79% 275B
-1.19%-1.21%+9.82%+10.61% 255B
-1.47%-1.53%+34.28%+98.89% 188B
+0.62%+0.38%-26.53%-60.68% 169B
Average -0.70%-0.44%+30.16%+47.49% 398.45B
Weighted average by Cap. -0.95%-0.34%+37.10%+65.79%

Financials

2026 *2027 *
Net sales 38.94B 34.29B 32.49B 29.33B 55.28B 3,733B 55.99B 389B 150B 1,909B 146B 143B 6,119B 40.31B 35.5B 33.63B 30.36B 57.23B 3,865B 57.97B 402B 155B 1,976B 151B 148B 6,335B
Net income 8.58B 7.56B 7.16B 6.46B 12.18B 823B 12.34B 85.65B 32.96B 421B 32.22B 31.52B 1,348B 9.39B 8.27B 7.84B 7.07B 13.33B 901B 13.51B 93.76B 36.08B 460B 35.27B 34.5B 1,476B
Net Debt 41.49B 36.53B 34.61B 31.25B 58.89B 3,978B 59.66B 414B 159B 2,033B 156B 152B 6,519B 35.82B 31.54B 29.88B 26.98B 50.85B 3,434B 51.5B 358B 138B 1,756B 134B 132B 5,629B
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
26-09-30 $421.51 -0.50% 3,129,477
26-09-29 $423.64 +1.32% 3,738,330
26-09-28 $418.13 +0.85% 2,917,874
26-09-25 $414.61 +2.11% 2,213,322
26-09-24 $406.04 -0.01% 2,525,238
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
34
Last Close Price
421.51USD
Average target price
390.94USD
Spread / Average Target
-7.25%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMGN Stock